Alterity Therapeutics ATHE
NASDAQ ATHE
$2.10 -0.29 (-12.16%)
As of: Oct 22, 2026 · 1:03 PM EDT

Alterity Therapeutics (ATHE) EBIT (2016 - 2018)

Updated

Alterity Therapeutics (ATHE) recorded EBIT of -$16.52 trillion in the year ended Jun 30, 2026, compared with -$7.74 trillion a year earlier.

Analysis

Alterity Therapeutics (ATHE) EBIT (2016 - 2018) Analysis & Trends

Starting with the year ended Jun 30, 2009, Alterity Therapeutics' EBIT history includes 18 years.

  • The figure for the year ended Jun 30, 2026 is the lowest annual EBIT in data going back to the year ended Jun 30, 2009.
  • Per Business Quant data, ATHE's EBIT was -$7.74 trillion in the year ended Jun 30, 2025, -$190,774 in the year ended Aug 29, 2024, -$137,021 in the year ended Dec 31, 2023 and -$9.15 trillion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn 6.18 Bn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn 6.43 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn 4.27 Bn
10 Alterity Therapeutics 36.75 Mn -46.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.83 Mn
Dec 31, 2017 -2.78 Mn
Dec 31, 2016 -2.74 Mn
API Access

Alterity Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ATHE&period=max&api_key=YOUR_API_KEY